MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/art.43144

Медицинская библиотека · Arthritis & rheumatology (Hoboken, N.J.) · 2025

Identification of Pathogenic PD-1+CD8+ T Cells for Effective Chimeric Antigen Receptor Therapy in a Murine Model of Sjögren Disease.

Ma Jin-Fen, Xu Ting, Zhu Hao-Xian, Chen Xiao-Min, Li Liang, Zhao Zhi-Bin, Lu Liwei, Li Yang, Lian Zhe-Xiong, Gao Cai-Yue

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Activated T cells play a pivotal pathogenic role in the progression of Sjögren disease (SjD); however, there are currently no targeted therapies specifically designed to address them. This study aims to identify pathogenic CD8+ T cells in SjD and develop targeted therapeutic strategies.

METHODS

Il12b-/-Il2ra-/- mice, a murine model for overlapping primary biliary cholangitis and SjD, were employed in this study. Pathogenic CD8+ T cells were identified through single-cell RNA sequencing and flow cytometry analyses of samples from both patients with SjD and relevant murine models. Shared T cell receptor analysis was conducted to trace the potential precursors of pathogenic CD8+ T cells. The efficacy of PD-1-targeted chimeric antigen receptor (CAR)-T cell therapy was evaluated through the assessment of salivary gland secretory function, immunologic profiles, and histopathological changes in the murine model.

RESULTS

We identified PD-1 as a comprehensive marker of clonally expanded and activated pathogenic CD8+ T cells in the salivary glands and peripheral tissues. Flow cytometry further confirmed the activation phenotype and cytotoxicity of PD-1+CD8+ T cells in the salivary glands of patients with SjD. Notably, the number of PD-1+CD8+ T cells in the labial glands positively correlated with disease activity in patients with SjD. These findings highlight the therapeutic potential of depleting PD-1+CD8+ T cells in SjD. Furthermore, PD-1-targeted CAR-T cell therapy significantly alleviated SjD symptoms in a murine model.

CONCLUSION

We identified the pathogenic role of PD-1+CD8+ T cells in both patients with SjD and a murine model and demonstrated the efficacy of PD-1-targeted CAR-T cell therapy in SjD model mice. Our findings suggest a promising avenue for developing clinical therapeutic strategies for patients with SjD.

Для цитирования: Ma Jin-Fen, Xu Ting, Zhu Hao-Xian, Chen Xiao-Min, Li Liang, Zhao Zhi-Bin, Lu Liwei, Li Yang, Lian Zhe-Xiong, Gao Cai-Yue. Identification of Pathogenic PD-1+CD8+ T Cells for Effective Chimeric Antigen Receptor Therapy in a Murine Model of Sjögren Disease.. Arthritis & rheumatology (Hoboken, N.J.). 2025. DOI: 10.1002/art.43144.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.